RAC1 and hepatocellular carcinoma: Consistent with these results, the p53-dependent GLS2 upregulation and its tumor suppressive role in HCC was associated with mitochondrial activation and enhanced antioxidant defense20,21 and, more recently, with inhibition of Rac1 activation and metastasis suppression38.